G. V. Van Dyke

Expression of CD25 defines peripheral blood mononuclear cells with productive versus latent HIV infection.

O. Ramilo, H. Zola, E. Vitetta, 1995, Journal of immunology.

Update on pathogenesis and treatment of acne

Delphine J. Lee, Jenny Kim, G. V. Van Dyke, 2003, Current opinion in pediatrics.

CD30 positive anaplastic large‐cell lymphoma mimicking Langerhans cell histiocytosis

S. Binder, N. Ezra, G. V. Van Dyke, 2008, Journal of cutaneous pathology.

An anti-CD45RO immunotoxin eliminates T cells latently infected with HIV-1 in vitro.

O. Ramilo, L. Picker, E. Vitetta, 1999, Proceedings of the National Academy of Sciences of the United States of America.

The use of cyclosporine, FK506, and SDZ NIM811 to prevent CD25- quiescent peripheral blood mononuclear cells from producing human immunodeficiency virus.

O. Ramilo, B. Rosenwirth, E. Vitetta, 1996, The Journal of infectious diseases.

Highly Purified 1000‐cSt Silicone Oil for Treatment of Human Immunodeficiency Virus‐Associated Facial Lipoatrophy: An Open Pilot Trial

S. Azen, M. Lai, D. Orentreich, 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Poliosis overlying a nevus with blue nevus features.

S. Binder, Lorraine C. Young, G. V. Van Dyke, 2008, Dermatology online journal.